Dr. Adam Kinnaird, a University of Alberta oncologist and former junior hockey player, has been recognized internationally for his groundbreaking research that could transform prostate cancer diagnostics worldwide. In March, he received the prestigious EAU Imaging Vision Award from the European Association of Urology, which honors the most innovative imaging study published in urology over the past year.
From Hockey to Medicine
Kinnaird's journey from tending goal for the Fort Saskatchewan Traders to becoming a leading urologic oncologist is marked by determination. While many teammates pursued professional hockey, Kinnaird focused on medicine, often studying on team buses with a whiteboard and sleeping in his car after late games. He later played for the Alberta Golden Bears, winning two national championships, and credits hockey for developing his leadership skills, which he now applies in the operating room and patient interactions.
Revolutionary Imaging Study
The award-winning trial compared the gold standard of prostate MRI to a new high-resolution micro ultrasound device. Conducted at 20 centers across eight countries with approximately 800 men, the randomized controlled trial demonstrated that micro ultrasound is non-inferior to MRI in detecting prostate cancer. Kinnaird emphasized that while MRI is effective, it is resource-intensive and requires sophisticated facilities. In contrast, micro ultrasound is a point-of-care exam that is portable, cheaper, and can be used anywhere with electricity, potentially expanding access to early detection globally.
Impact on Patient Care
At the University of Alberta Hospital, which serves patients from north of Red Deer to the Arctic Circle, Kinnaird performs all prostate biopsies for these regions. The hospital's high clinical volume made it an ideal setting for the research. Kinnaird noted that the new technology could improve early detection and reduce healthcare costs, benefiting millions of men worldwide.
